Preface: NRP 104 marvelous drug is been designed and developed by world famous pharmaceutical formulators from Virginia, the United States. This drug is considered the most sophisticated preparation based on formula which is Conditionally Bio-reversible Derivative i.e. CBD of Amphetamine the widely accepted stimulant greatly used for treatment of ADHD disorders. The development is undertaken mainly based on company’s proprietary Carrierwave technology expertise. The NRPH which is New River Pharmaceuticals Inc. is always striving for inventing newer molecular formula.

ADHD: Attention Deficit Hyperactivity Disorder impede with individual’s aptitude for standardizing bustle levels, performance and continue high lighting on chore in proper means of developments. ADHD defines the childhood psychiatric disorders which have also been reported in some adults nowadays according to various research and studies across the world.

NRP 104: NRP 104 is the wonder preparation made by fusing Amphetamine to the specific Amino Acid which is reported to have been significantly based on the formula to extend better protection against the over dosage as well as reducing the probability of desire than Amphetamine formulation which is currently available in the markets for the most appropriate treatment of ADHD disorders when taken strictly as per requisite prescription by medical practitioner. The product is also strong enough to reduce the eventualities of either patient’s abusing the drug or diversion of the drug.

Progress Track: NRPH has applied to the FDA for using NRP104 for treatment of pediatric ADHD disorders. The company has also signed the collaboration deal with Shire Pharmaceuticals Group Plc for the global commercialization for NRP 104.